ARCHIVES

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Pinkel Corrects Report On ALL – Two Drugs Are Better Than One

April 21, 1978

Funding Opportunities: NKCA Offers Young Researcher Award

March 6, 1998

In Brief: Hohn Named President, CEO Of Roswell Park; Mendelsohn Honored; AACE Elects Officers

February 7, 1997

Herberman: Progress Made To Stabilize NSABP

September 9, 1994

Drug Slows Tumor Growth In Metastatic Kidney Cancer

July 26, 2002

Fallout Over PSA Guidance Continues—Specialty Groups Dissent, Congress Attacks

July 20, 2012